Anzeige
Mehr »
Freitag, 25.07.2025 - Börsentäglich über 12.000 News
Richtig investiert verwandelt der Goldpreis jeden Euro in glänzendes Vermögen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QQEL | ISIN: CA68405H1001 | Ticker-Symbol: 8BN
Tradegate
23.07.25 | 08:57
0,112 Euro
+14,29 % +0,014
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
OPTIMI HEALTH CORP Chart 1 Jahr
5-Tage-Chart
OPTIMI HEALTH CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0900,10914:48
0,0910,10914:48

Aktuelle News zur OPTIMI HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.07.Optimi Health Corp: Optimi arranges $3.45-million debenture financing2
18.07.Optimi Health launches $3.45M convertible debenture offering1
18.07.Optimi Health Corp.: Optimi Health Announces $3.45 Million Convertible Financing and Extension of Secured Term Loan362Vancouver, British Columbia--(Newsfile Corp. - July 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of...
► Artikel lesen
08.05.Optimi Health Corp: Optimi Health exports MDMA capsules to Australia1
08.05.Optimi Health Corp.: Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy378Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of GMP-grade...
► Artikel lesen
05.05.Optimi Health Corp: Optimi Health formally recognized by U.S. FDA4
05.05.Optimi Health Corp.: Optimi Health Obtains U.S. FDA Drug Establishment Registration387Vancouver, British Columbia--(Newsfile Corp. - May 5, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin...
► Artikel lesen
12.03.Optimi Health Corp: Optimi receives more import permits for MDMA4
OPTIMI HEALTH Aktie jetzt für 0€ handeln
12.03.Optimi Health Corp.: Optimi Health Provides Corporate Update340Vancouver, British Columbia--(Newsfile Corp. - March 12, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed manufacturer...
► Artikel lesen
29.01.Optimi Health Corp: Optimi completes production batch of 4K MDMA capsules2
29.01.Optimi Health Corp.: Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program311Vancouver, British Columbia--(Newsfile Corp. - January 29, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian-based company licensed by Health...
► Artikel lesen
29.01.Optimi Health Corp: Optimi closes $395,000 final tranche of placement3
29.01.Optimi Health Corp.: Optimi Health Announces Closing of Non-Brokered Private Placement and Debt Settlement494Vancouver, British Columbia--(Newsfile Corp. - January 28, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics...
► Artikel lesen
17.01.Optimi Health Corp.: Optimi Health Provides Corporate Update924Vancouver, British Columbia--(Newsfile Corp. - January 17, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics...
► Artikel lesen
13.01.Optimi Health Corp.: Optimi Health Reports First Patients Dosed in Landmark Natural Psilocybin Study in New Zealand241Vancouver, British Columbia--(Newsfile Corp. - January 13, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic...
► Artikel lesen
06.01.Optimi Health Corp.: Optimi Health Completes Second MDMA Shipment to Australia and Expands 2025 Production Forecast to Support Over 5,000 Patients Globally272Vancouver, British Columbia--(Newsfile Corp. - January 6, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic...
► Artikel lesen
17.12.24Optimi Health Corp.: Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial356Agreement Supports Phase IIb and Future Phase III Trial Development,Addressing Critical Needs in Palliative Care Using Optimi's Natural Psilocybin ExtractVancouver, British Columbia--(Newsfile Corp....
► Artikel lesen
10.12.24Psyence Biomedical Ltd.: Psyence Biomed Executes Binding Agreements with Optimi Health Corp.135NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced that it has progressed beyond the previously-announced non-binding...
► Artikel lesen
23.10.24Optimi Health Corp.: Optimi Health Announces First PTSD Patients Treated with MDMA Capsules in Australia492Vancouver, British Columbia--(Newsfile Corp. - October 23, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic...
► Artikel lesen
21.10.24Optimi Health Corp.: Optimi Health Announces Leadership Transition336Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a GMP-compliant, Health Canada-licensed manufacturer...
► Artikel lesen
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1